Experiment: 2LO6

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	2 mM [U-100% 13C; U-100% 15N] Nrd1 polypeptide, 2.3 mM phosphopeptide	90% H2O/10% D2O	100	8	ambient	293
2	2D 1H-13C HSQC	2 mM [U-100% 13C; U-100% 15N] Nrd1 polypeptide, 2.3 mM phosphopeptide	90% H2O/10% D2O	100	8	ambient	293
3	3D CBCA(CO)NH	2 mM [U-100% 13C; U-100% 15N] Nrd1 polypeptide, 2.3 mM phosphopeptide	90% H2O/10% D2O	100	8	ambient	293
4	3D HNCA	2 mM [U-100% 13C; U-100% 15N] Nrd1 polypeptide, 2.3 mM phosphopeptide	90% H2O/10% D2O	100	8	ambient	293
5	3D HNCACB	2 mM [U-100% 13C; U-100% 15N] Nrd1 polypeptide, 2.3 mM phosphopeptide	90% H2O/10% D2O	100	8	ambient	293
6	3D HN(CO)CA	2 mM [U-100% 13C; U-100% 15N] Nrd1 polypeptide, 2.3 mM phosphopeptide	90% H2O/10% D2O	100	8	ambient	293
7	3D HCCH-TOCSY	2 mM [U-100% 13C; U-100% 15N] Nrd1 polypeptide, 2.3 mM phosphopeptide	90% H2O/10% D2O	100	8	ambient	293
8	3D 1H-15N NOESY	2 mM [U-100% 13C; U-100% 15N] Nrd1 polypeptide, 2.3 mM phosphopeptide	90% H2O/10% D2O	100	8	ambient	293
9	3D 1H-13C NOESY aliphatic	2 mM [U-100% 13C; U-100% 15N] Nrd1 polypeptide, 2.3 mM phosphopeptide	90% H2O/10% D2O	100	8	ambient	293
10	3D filtered-edited NOESY	2 mM [U-100% 13C; U-100% 15N] Nrd1 polypeptide, 2.3 mM phosphopeptide	90% H2O/10% D2O	100	8	ambient	293
11	2D filtered-filtered NOESY	2 mM [U-100% 13C; U-100% 15N] Nrd1 polypeptide, 2.3 mM phosphopeptide	90% H2O/10% D2O	100	8	ambient	293

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	600
2	Bruker	AVANCE	900

NMR Refinement
Method	Details	Software
torsion angle dynamics, simulated annealing		TopSpin

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	40
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	TopSpin		Bruker Biospin
2	chemical shift assignment	Sparky		Goddard
3	structure solution	CYANA		Guntert, Mumenthaler and Wuthrich
4	refinement	Amber		Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, and Kollm
5	geometry optimization	CING		Vuister, Doreleijers, da Silva
6	refinement	CYANA		Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.